Evaluation of prostate cancer using FDG-PET

Acta Urologica Japonica

Volumn 46, Issue 11, 2000, Pages 851-853

  Kanamaru, Hiroshi ^b   Oyama, Nobuyuki ^b   Akino, Hironobu ^b   Okada, Kenichiro ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b NONE

Author keywords

FDG; PET; Prostate cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EVALUATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROSTATE CANCER;

BONE NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034527078     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Pantronas NJ, Chiro GD, Kufta C, et al.: Prediction of survival in glioma patients by means of position emission tomography. J Neurosurg 62: 816-822, 1985
2. Rege S, Maass A, Chaiken L, et al.: Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73: 3047-3058, 1994
3. Strauss LG, Clorius JH, Schlag P, et al.: Recurrence of colorectal tumors: PET evaluation. Radiology 170: 329-332, 1989
4. Effert PJ, Bares R, Handt S, et al.: Metabolic imaging of untreated prostate cancer by positron emission tomography with 18 fluorine-labeled deoxyglucose. J Urol 155: 994-998, 1996
5. Laubenbacher C, Hofer C, Avril N, et al.: F-18 FDG PET for differentiation of local recurrent prostate cancer and scar. J Nucl Med 36(Suppl 1): 198, 1995
6. Oyama N, Akino H, Suzuki Y, et al.: The increased accumulation of 18-fluorodeoxyglucose in untreated prostate cancer. Jpn J Clin Oncol 29: 623-629, 1999